Cornell Tech has final Open Studio before move to new campus

Cornell Tech's Open Studio, held for the final time at the Google building campus, gives budding entrepreneurs a chance to pitch their ideas to several hundred people, including business leaders.

Initiative will connect research across NYC, Ithaca campuses

A new initiative on academic integration will connect research across Weill Cornell Medicine, Cornell Tech and the Ithaca campus. Dr. Gary Koretzky will lead the effort, which will tie together investigation and discovery.

Weill Cornell team creates breakthrough on blood disorders

Researchers at Weill Cornell Medicine have discovered an innovative method to make an unlimited supply of healthy blood cells from the readily available cells that line blood vessels.

'Bookmarks' on stem cell genes preserve cell identity

Stem cells preserve their identities after cell division by using a series of protein "bookmarks" on their genes, according to new research published by scientists at Weill Cornell Medicine.

Cornell Chronicle default image

Researchers ID drug that blocks some blood cancers

A compound identified by Weill Cornell Medicine scientists inhibits the growth of a rare blood cancer found in people with HIV-AIDS.

Weill Cornell Medicine doctoral students present their work

At the 37th Annual Vincent du Vigneaud Memorial Symposium April 18, posters displayed research from students at every stage along the path to a doctorate.

Study reveals how HIV virus destroys lung tissue

Up to 30 percent of HIV patients who are appropriately treated with antiretroviral therapies develop emphysema. New research from Weill Cornell Medicine investigators has uncovered a mechanism that might explain why this lung damage occurs.

Students learn to commercialize medical technologies

The Bench to Bedside Initiative program, part of Weill Cornell Medicine's entrepreneurship lab, helps medical and doctoral students, clinicians and researchers launch technologies into startups.

New method more accurately models colorectal cancer

Weill Cornell Medicine and Memorial Sloan Kettering Cancer Center researchers have developed a preclinical model of colorectal cancer in which the disease forms in the correct anatomical location.